Park Tae Yong, Choi Moon Young, Kim Dong Soo, Yeo Jeong Kyun, Rajasekaran Mahadevan, Park Min Gu
Department of Medicine, Graduate School, Korea University, Seoul, Korea.
Department of Urology, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu, Korea.
World J Mens Health. 2024 Jan;42(1):178-187. doi: 10.5534/wjmh.220274. Epub 2023 Apr 19.
This study analyzed changes in body composition and physical fitness in men with testosterone deficiency (TD) after testosterone treatment (TT) and examined the correlations of body composition and physical fitness with serum testosterone levels and hypogonadal symptoms.
Seventy patients with TD were divided into control (group I, n=23) and experimental (group II, n=47) groups. Patients in the experimental group were administered intramuscular testosterone enanthate (250 mg) for six months. The aging males symptom scale (AMS) score, international prostate symptom score (IPSS), body mass index, waist circumference, and serum laboratory values were measured at baseline and at the end of the study. Bioelectrical impedance analysis was used to assess the patients' body composition. Seven types of basic exercise tests were used to evaluate the patients' physical fitness.
After six months, there were no significant differences in group I, while group II had significantly improved IPSS and AMS scores; increased hemoglobin, hematocrit, prostate-specific antigen, and testosterone levels and skeletal muscle mass; and waist circumference, and body fat mass. All elements of the physical fitness test were significantly improved in group II, with the exceptions of flexibility and endurance. Decreased waist circumference was correlated with changes in testosterone levels in group II, and the IPSS, cardiorespiratory fitness, and agility were correlated with improved hypogonadal symptoms.
TT improved the hypogonadal and lower urinary tract symptoms in patients with TD and improved body composition, physical fitness, and metabolic syndrome parameters. Increased testosterone and improved hypogonadal symptoms were correlated with a decrease in waist circumference and an improvement in cardiorespiratory fitness and agility. As such, when implementing TT, we should consider whether these areas may be improved, as this can help to predict the effect.
本研究分析了睾酮缺乏(TD)男性在接受睾酮治疗(TT)后身体成分和体能的变化,并探讨了身体成分和体能与血清睾酮水平及性腺功能减退症状之间的相关性。
70例TD患者分为对照组(I组,n = 23)和实验组(II组,n = 47)。实验组患者接受肌肉注射庚酸睾酮(250 mg),为期6个月。在基线和研究结束时测量衰老男性症状量表(AMS)评分、国际前列腺症状评分(IPSS)、体重指数、腰围和血清实验室值。采用生物电阻抗分析评估患者的身体成分。使用七种基本运动测试来评估患者的体能。
6个月后,I组无显著差异,而II组的IPSS和AMS评分显著改善;血红蛋白、血细胞比容、前列腺特异性抗原、睾酮水平和骨骼肌质量增加;腰围和体脂质量降低。II组体能测试的所有项目均显著改善,但柔韧性和耐力除外。II组腰围的减小与睾酮水平的变化相关,IPSS、心肺适能和敏捷性与性腺功能减退症状的改善相关。
TT改善了TD患者的性腺功能减退和下尿路症状,改善了身体成分、体能和代谢综合征参数。睾酮增加和性腺功能减退症状改善与腰围减小以及心肺适能和敏捷性提高相关。因此,在实施TT时,我们应考虑这些方面是否可能得到改善,因为这有助于预测效果。